Literature DB >> 17612571

Distinct cardiodynamic and molecular characteristics during early and late stages of sepsis-induced myocardial dysfunction.

Mani Chopra1, Avadhesh C Sharma.   

Abstract

We hypothesized that progressive decline in myocardial performance would correlate with upregulation of markers for apoptotic mechanisms following increased duration of polymicrobial sepsis in the rat. Male Sprague-Dawley rats (350-400 g) were randomized into sham, 1-, 3- and 7-day sepsis groups. Each septic rat received 200 mg/kg cecal inoculum intraperitoneally (i.p). The post-mortem analysis showed a severely inflamed peritoneum with the presence of pus in all septic animals that was directly proportional to the duration of sepsis. We observed 10, 33 and 42% mortality in the 1-, 3- and 7-day sepsis groups, respectively. Septic animals at 3 and 7 days exhibited an increased wet lung/total body weight and heart weight/total body weight. A significant increase in total cardiac troponin I (cTnI) and C Reactive Protein (CRP) and endothelin-1 (ET-1) was also observed with an increased duration of sepsis. Myocardial ET-1 concentration in the 7-day post-sepsis group was significantly elevated compared to the sham and 1-day post-sepsis groups. Sepsis also produced a significant decrease in the mean arterial pressure in the 7-day post-sepsis group and tachycardia in the 1-, 3-, and 7-day post-sepsis groups compared to the sham group. A significant prolongation of the left ventricular isovolumic relaxation rate constant, tau, and left ventricular end-diastolic pressure in the 1-, 3- and 7-day post-sepsis groups compared to the sham group was observed. In addition, a significant decrease in the rates of left ventricular relaxation (-dP/dt) and contraction (+dP/dt) in the 3- and 7-day post-sepsis groups compared to the sham and 1-day post-sepsis group was observed. Sepsis produced a significant upregulation in the expression of myocardial TRADD, cytosolic active caspase-3, the Bax/Bcl(2) ratio, and the mitochondrial release of cytochrome C in the 3- and 7-day post-sepsis groups. We observed a progressive increase in the number of TUNEL positive nuclei, cytosolic caspase-3 activation and co-localization of PARP in the nuclei at 1, 3 and 7 days post-sepsis. These data suggest that the progression of sepsis from 1 day to 3-7 days produce distinct cardiodynamic characteristics with a more profound effect during later stages. The sepsis-induced decline in myocardial performance correlates with the induction of myocardial apoptosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17612571      PMCID: PMC1986677          DOI: 10.1016/j.lfs.2007.05.021

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  45 in total

1.  Release kinetics of serum cardiac troponin I in ischemic myocardial injury.

Authors:  J P Bertinchant; C Larue; I Pernel; B Ledermann; P Fabbro-Peray; L Beck; C Calzolari; S Trinquier; J Nigond; B Pau
Journal:  Clin Biochem       Date:  1996-12       Impact factor: 3.281

2.  Sepsis alters myocardial and plasma concentrations of endothelin and nitric oxide in rats.

Authors:  A C Sharma; S J Motew; S Farias; K J Alden; H B Bosmann; W R Law; J L Ferguson
Journal:  J Mol Cell Cardiol       Date:  1997-05       Impact factor: 5.000

3.  Stretch-induced programmed myocyte cell death.

Authors:  W Cheng; B Li; J Kajstura; P Li; M S Wolin; E H Sonnenblick; T H Hintze; G Olivetti; P Anversa
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

Review 4.  Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy.

Authors:  J E Parrillo; M M Parker; C Natanson; A F Suffredini; R L Danner; R E Cunnion; F P Ognibene
Journal:  Ann Intern Med       Date:  1990-08-01       Impact factor: 25.391

5.  Effects of a dobutamine-induced increase in splanchnic blood flow on hepatic metabolic activity in patients with septic shock.

Authors:  H Reinelt; P Radermacher; G Fischer; W Geisser; U Wachter; H Wiedeck; M Georgieff; J Vogt
Journal:  Anesthesiology       Date:  1997-04       Impact factor: 7.892

6.  MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway.

Authors:  J Raingeaud; A J Whitmarsh; T Barrett; B Dérijard; R J Davis
Journal:  Mol Cell Biol       Date:  1996-03       Impact factor: 4.272

7.  Profound but reversible myocardial depression in patients with septic shock.

Authors:  M M Parker; J H Shelhamer; S L Bacharach; M V Green; C Natanson; T M Frederick; B A Damske; J E Parrillo
Journal:  Ann Intern Med       Date:  1984-04       Impact factor: 25.391

8.  Norepinephrine alone versus norepinephrine plus low-dose dopamine: enhanced renal blood flow with combination pressor therapy.

Authors:  G L Schaer; M P Fink; J E Parrillo
Journal:  Crit Care Med       Date:  1985-06       Impact factor: 7.598

9.  Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis.

Authors:  Z Xia; M Dickens; J Raingeaud; R J Davis; M E Greenberg
Journal:  Science       Date:  1995-11-24       Impact factor: 47.728

10.  Stimulation of the p38 mitogen-activated protein kinase pathway in neonatal rat ventricular myocytes by the G protein-coupled receptor agonists, endothelin-1 and phenylephrine: a role in cardiac myocyte hypertrophy?

Authors:  A Clerk; A Michael; P H Sugden
Journal:  J Cell Biol       Date:  1998-07-27       Impact factor: 10.539

View more
  15 in total

1.  Splenocyte apoptosis and autophagy is mediated by interferon regulatory factor 1 during murine endotoxemia.

Authors:  Lemeng Zhang; Jon S Cardinal; Pinhua Pan; Brian R Rosborough; Ying Chang; Wei Yan; Hai Huang; Timothy R Billiar; Matthew R Rosengart; Allan Tsung
Journal:  Shock       Date:  2012-05       Impact factor: 3.454

2.  Interferon regulatory factor-1 regulates the autophagic response in LPS-stimulated macrophages through nitric oxide.

Authors:  Lemeng Zhang; Jon S Cardinal; Runalia Bahar; John Evankovich; Hai Huang; Gary Nace; Timothy R Billiar; Matthew R Rosengart; Pinhua Pan; Allan Tsung
Journal:  Mol Med       Date:  2012-03-27       Impact factor: 6.354

Review 3.  Signaling mechanism of poly(ADP-ribose) polymerase-1 (PARP-1) in inflammatory diseases.

Authors:  Xueqing Ba; Nisha Jain Garg
Journal:  Am J Pathol       Date:  2011-03       Impact factor: 4.307

Review 4.  Energy crisis: the role of oxidative phosphorylation in acute inflammation and sepsis.

Authors:  Icksoo Lee; Maik Hüttemann
Journal:  Biochim Biophys Acta       Date:  2014-06-04

5.  Caspase-3 knock-down reverses contractile dysfunction induced by sepsis in adult rat ventricular myocytes.

Authors:  Mani Chopra; Padmalaya Das; Avadhesh C Sharma
Journal:  Br J Pharmacol       Date:  2010-03-19       Impact factor: 8.739

6.  Inhibition of endotoxin-induced airway epithelial cell injury by a novel family of pyrrol derivates.

Authors:  Nuria E Cabrera-Benítez; Eduardo Pérez-Roth; Ángela Ramos-Nuez; Ithaisa Sologuren; José M Padrón; Arthur S Slutsky; Jesús Villar
Journal:  Lab Invest       Date:  2016-03-21       Impact factor: 5.662

7.  Contractile response of norepinephrine is modulated by caspase-3 in adult rat ventricular myocytes isolated from septic rat heart.

Authors:  Mani Chopra; Avadhesh C Sharma
Journal:  Pharmacol Res       Date:  2009-04-24       Impact factor: 7.658

8.  Upregulation of myocardial syntaxin1A is associated with an early stage of polymicrobial sepsis.

Authors:  Padmalaya Das; Mani Chopra; Avadhesh C Sharma
Journal:  Mol Cell Biochem       Date:  2008-11-28       Impact factor: 3.396

9.  Temporally Distinct Regulation of Pathways Contributing to Cardiac Proteostasis During the Acute and Recovery Phases of Sepsis.

Authors:  Kristen T Crowell; Samantha Moreno; Jennifer L Steiner; Catherine S Coleman; David I Soybel; Charles H Lang
Journal:  Shock       Date:  2018-12       Impact factor: 3.454

Review 10.  Inflammation-induced DNA damage, mutations and cancer.

Authors:  Jennifer Kay; Elina Thadhani; Leona Samson; Bevin Engelward
Journal:  DNA Repair (Amst)       Date:  2019-07-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.